Scarica l'app Stockscreener
5.00
21.07%
0.87
Pre-mercato:
5.19
0.19
+3.80%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Agenus Inc Borsa (AGEN) Ultime notizie
Zydus Lifesciences to acquire Agenus’s two biologics facilities for USD 125M - Medical Buyer
With plans to acquire US-based genus Inc, Zydus Lifesciences set to enter the global biologics CDMO business - financialexpress.com
Zydus Lifesciences Subsidiary Zynext to Acquire 5.9% Stake in Agenus for $16 Million - India Infoline
Zydus enters global biologics CDMO business, plans to acquire Agenus’ U.S. manufacturing facilities to accelerate development of innovative therapies - Equity Bulls
Zydus announces plan to acquire US manufacturing units of Agenus Inc - The Indian Express
Agenus Inc. announced that it expects to receive $15.75 million in funding from Zydus Lifesciences Limited - marketscreener.com
Zydus to acquire US biotech firm Agenus’ facilities in California - The Economic Times
Agenus Stock Is Trading Higher Tuesday: What's Going On? - Benzinga
Zydus to acquire 2 biologics manufacturing units in U.S. from Agenus for $125 million - The Hindu
Agenus to Sell US Manufacturing Facilities to Zydus Lifesciences - marketscreener.com
Zydus buys Agenus' biologics plants in US for $125 mn, licenses cancer therapy | Company Business News - Mint
Zydus bolsters global biologics play with Agenus acquisition, immuno-oncology licensing pact - Fortune India
Zydus inks pact to acquire stake in US firm to enter contract manufacturing space - theweek.in
Zynext Ventures acquires stake in Agenus, expands its immuno-oncology pipeline and global reach - Yahoo Finance
Zydus Lifesciences to Enter the Global CDMO Business - Contract Pharma
Zydus Life To Buy Agenus US Facilities For $75 Million For Entry In Biologics CDMO - NDTV Profit
Agenus (AGEN) Rises on Zydus Partnership to Boost Cancer Therapy - GuruFocus
Zydus forays into global bilogics CDMO business through acquisition of two facilities of Agenus Inc in the US - The Hindu BusinessLine
Zydus acquires Agenus biologics facilities for CDMO expansion - Investing.com Australia
Zydus signs deal with Agenus for BOT and BAL cancer therapies in India - Business Standard
Zydus to Enter Global Biologics CDMO Business Plans to Acquire Agenus U.S. Manufacturing Facilities to Accelerate Development of Innovative Therapies - Tribune India
Agenus (AGEN) Sells Biologics Facilities to Zydus Lifesciences | AGEN Stock News - GuruFocus
Zydus to enter global biologics CDMO business: Plans to acquire Agenus' U.S. manufacturing facilities to accelerate development of innovative therapies | AGEN Stock News - GuruFocus
Zydus Lifesciences to invest $16 million in US-based Agenus for 5.9% stake - CNBC TV18
Agenus and Zydus Lifesciences enter $141 M strategic collaboration for biologics manufacturing in US - BioSpectrum India
Zydus Lifesciences in licensing deal with America's Agenus for cancer therapy - Moneycontrol
Agenus (AGEN) Enters Strategic Partnership with Zydus Lifesciences | AGEN Stock News - GuruFocus
Zydus to enter global biologics CDMO business: Plans to acquire Agenus' U.S. manufacturing facilities to accelerate development of innovative therapies - Nasdaq
Agenus inks $141M deal with Zydus for cancer drugs, facilities - Investing.com Nigeria
Agenus stock climbs Zydus deal for BOT/BAL (AGEN:NASDAQ) - Seeking Alpha
Agenus shares leap on strategic collaboration with Zydus Lifesciences - Investing.com
Zydus Lifesciences Enters Into Definitive Agreement With Agenus West LLC, And Agenus Inc, USA - marketscreener.com
Agenus and Zydus Lifesciences Enter $141M Strategic Collaboratio - GuruFocus
Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the US - medianet.com.au
Agenus and Zydus Lifesciences Enter $141 Mln Strategic Collaboration to Advance BOT/BAL, Expand Zydus' Biologics Manufacturing in the US - marketscreener.com
Major Biotech Deal: Agenus Secures $141M from Zydus for Manufacturing Assets and Cancer Drug Rights - Stock Titan
Why Credo Technology Group Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket - Benzinga
Stocks in play: Allied Gold Corporation - The Globe and Mail
Agenus presents new translational data at 2025 ASCO meeting - TipRanks
Agenus (AGEN) Reports Promising Data on Botensilimab Therapy | AGEN Stock News - GuruFocus
Agenus Presents New Data at ASCO Highlighting Botensilimab's Imm - GuruFocus
Cancer Breakthrough: How Botensilimab Activates Immune Response in 'Untreatable' Colorectal CancerASCO Data - Stock Titan
Agenus (NASDAQ:AGEN) Share Price Passes Above 200-Day Moving Average – Should You Sell? - Defense World
Peptide Cancer Vaccine Market Detailed In New Research Report - openPR.com
Agenus (NASDAQ:AGEN) Raised to Hold at Wall Street Zen - Defense World
Agenus: Big On BOT/BAL As Cash Burn And Catalysts Collide (AGEN) - Seeking Alpha
Agenus Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationAGEN - ACCESS Newswire
Agenus Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More InformationAGEN - ACCESS Newswire
What is B. Riley’s Estimate for Agenus FY2025 Earnings? - Defense World
Despite Fast-paced Momentum, Agenus (AGEN) Is Still a Bargain Stock - Yahoo Finance
Richard Goldberg joins Agenus as chief development officer - The Cancer Letter
Agenus says expanded MSS mCRC cohort data to be presented at ESMO GI - Yahoo Finance
HC Wainwright Weighs in on Agenus’ Q2 Earnings (NASDAQ:AGEN) - Defense World
Agenus (AGEN) Reveals Insights from Phase 1 Trial on Cancer Trea - GuruFocus
Agenus Announces New Data from Expanded MSS Metastatic Colorecta - GuruFocus
Agenus (AGEN) Reveals Insights from Phase 1 Trial on Cancer Treatment | AGEN Stock News - GuruFocus
Major Clinical Trial Update: Agenus Reveals New Colorectal Cancer Data From 123-Patient Study at ESMO - Stock Titan
Agenus Announces New Data from Expanded MSS Metastatic Colorectal Cancer Cohort to be Presented at ESMO GI 2025 - The Joplin Globe
Agenus Inc. (NASDAQ:AGEN) Shares Acquired by Barclays PLC - Defense World
Agenus Inc. (NASDAQ:AGEN) Receives Average Recommendation of “Hold” from Brokerages - Defense World
Robert W. Baird Forecasts Strong Price Appreciation for Agenus (NASDAQ:AGEN) Stock - Defense World
Peptide Cancer Vaccine Market Set to Witness Significant Growth - openPR.com
Wells Fargo & Company MN Decreases Holdings in Agenus Inc. (NASDAQ:AGEN) - Defense World
Agenus (AGEN) Target Price Raised by Analyst Baird | AGEN Stock News - GuruFocus
Agenus (AGEN) Registers Plan to Offer 165,000 Common Shares | AGEN Stock News - GuruFocus
Analyst Reiterates Neutral Rating for Agenus (AGEN) | AGEN Stock News - GuruFocus
0.87%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):